Home Other Building Blocks 31637-97-5
31637-97-5,MFCD00865727
Catalog No.:AA00BZDU

31637-97-5 | ETOFIBRATE

Pack Size
Purity
Availability
Price(USD)
Quantity
  
1mg
98%
in stock  
$7.00   $5.00
- +
10mg
98%
in stock  
$13.00   $9.00
- +
25mg
98%
in stock  
$21.00   $15.00
- +
100mg
95%
in stock  
$59.00   $42.00
- +
250mg
95%
in stock  
$107.00   $75.00
- +
1g
95%
in stock  
$283.00   $198.00
- +
  • Technical Information
  • Properties
  • Literature
  • Request for Quotation
  • Download SDS
  • Technical Information
  • Properties
  • Literature
Technical Information
Catalog Number:
AA00BZDU
Chemical Name:
ETOFIBRATE
CAS Number:
31637-97-5
Molecular Formula:
C18H18ClNO5
Molecular Weight:
363.7922
MDL Number:
MFCD00865727
SMILES:
Clc1ccc(cc1)OC(C(=O)OCCOC(=O)c1cccnc1)(C)C
Properties
Computed Properties
 
Complexity:
449  
Covalently-Bonded Unit Count:
1  
Heavy Atom Count:
25  
Hydrogen Bond Acceptor Count:
6  
Rotatable Bond Count:
9  
XLogP3:
3.5  

Literature

Title: Nutritional and metabolic status of HIV-positive patients with lipodystrophy during one year of follow-up.

Journal: Clinics (Sao Paulo, Brazil) 20110301

Title: Human health risk assessment of pharmaceuticals in water: issues and challenges ahead.

Journal: International journal of environmental research and public health 20101101

Title: Methods of chromatographic determination of medicines decreasing the level of cholesterol.

Journal: Acta poloniae pharmaceutica 20100101

Title: [Efficacy and safety of etofibrate in patients with non-proliferative diabetic retinopathy].

Journal: Klinische Monatsblatter fur Augenheilkunde 20090701

Title: Etofibrate enhances 123I-LDL-binding in human liver.

Journal: Hellenic journal of nuclear medicine 20090101

Title: Substituted tertiary phosphine Ru(II) organometallics: catalytic utility on the hydrolysis of etofibrate in pharmaceuticals.

Journal: Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy 20081001

Title: Peroxisome proliferator activated receptors and lipoprotein metabolism.

Journal: PPAR research 20080101

Title: Determination of etofibrate, fenofibrate, and atorvastatin in pharmaceutical preparations and plasma using differential pulse polarographic and square wave voltammetric techniques.

Journal: Journal of AOAC International 20080101

Title: High performance liquid chromatographic determination of etofibrate and its hydrolysis products.

Journal: Journal of pharmaceutical and biomedical analysis 20070104

Title: Fenofibrate: a novel formulation (Triglide) in the treatment of lipid disorders: a review.

Journal: International journal of nanomedicine 20060601

Title: Influence of etofibrate on LDL-subtype distribution in patients with diabetic dyslipoproteinemia.

Journal: Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association 20030901

Title: Mass spectrometric monitoring of the degradation and elimination efficiency for hardly eliminable and hardly biodegradable polar compounds by membrane bioreactors.

Journal: Water science and technology : a journal of the International Association on Water Pollution Research 20020101

Title: Effects of etofibrate upon the metabolism of chylomicron-like emulsions in patients with coronary artery disease.

Journal: Atherosclerosis 20010201

Title: Etofibrate but not controlled-release niacin decreases LDL cholesterol and lipoprotein (a) in type IIb dyslipidemic subjects.

Journal: Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas 20010201

Title: Treatment of dyslipoproteinemia in the metabolic syndrome.

Journal: Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association 20010101

Title: Studies with etofibrate in the rat. Part I: Effects on glycerol, free fatty acid and triacylglycerol metabolism.

Journal: Biochimica et biophysica acta 19881104

Title: Mitochondrial myopathy--a result of clofibrate/etofibrate treatment? Case report.

Journal: Acta neuropathologica 19850101

Title: Bocos C, et al. Effect of etofibrate on bile production in the normolipidemic rat. Gen Pharmacol. 1995 May;26(3):537-42.

Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Related Products of 31637-97-5
Tags:31637-97-5 Molecular Formula|31637-97-5 MDL|31637-97-5 SMILES|31637-97-5 ETOFIBRATE